Skip to main content

Russell Investments Group, Ltd.

Position in DSGN — Design Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in DSGN

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$270,647
+$33,953 QoQ
Shares Held
25,437
+0.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,224,048,594 across 266 Biotechnology names. DSGN ranks #141 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DSGN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $270,647 25,437
2025-12-31 $236,694 25,234
2025-09-30 $48,018 6,377
2025-06-30 $12,667 3,759
2025-03-31 $15,208 3,940
2024-12-31 $18,874 3,059
2024-09-30 $24,166 4,492
2024-06-30 $27,617 8,244
2024-03-31 $17,373 4,311
2023-12-31 $4,939 1,864
2023-09-30 $1,446 613
2023-06-30 $8,781 1,394
2023-03-31 $5,723 992
2022-12-31 $10,177 992
2022-09-30 $16,586 992
2022-06-30 $32,816 2,344